Tag Archives: NASDAQ:ZGNX

Zogenix (ZGNX) Receives a Buy from Needham

In a report released today, Serge Belanger from Needham maintained a Buy rating on Zogenix (ZGNX – Research Report), with a price target of $58.00. The company’s shares closed last Monday at $47.11. According to TipRanks.com, Belanger is a 3-star

Zogenix (ZGNX) Receives a Buy from Mizuho Securities

Mizuho Securities analyst Difei Yang maintained a Buy rating on Zogenix (ZGNX – Research Report) today and set a price target of $65.00. The company’s shares closed last Monday at $46.83. According to TipRanks.com, Yang ‘s ranking currently consits of

Analysts Offer Insights on Healthcare Companies: Zogenix (NASDAQ: ZGNX) and Aslan Pharmaceuticals (NASDAQ: ASLN)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Zogenix (ZGNX – Research Report) and Aslan Pharmaceuticals (ASLN – Research Report) with bullish sentiments. Zogenix (ZGNX) In a report released today,

Zogenix (ZGNX) Gets a Buy Rating from Mizuho Securities

Mizuho Securities analyst Difei Yang maintained a Buy rating on Zogenix (ZGNX – Research Report) today and set a price target of $65.00. The company’s shares closed last Monday at $42.41. According to TipRanks.com, Yang is a 3-star analyst with

Analysts Are Bullish on Top Healthcare Stocks: Zogenix (ZGNX), Stryker Corporation (SYK)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Zogenix (ZGNX – Research Report), Stryker Corporation (SYK – Research Report) and Global Blood Therapeutics (GBT – Research Report) with bullish sentiments.

Zogenix (ZGNX) Received its Third Buy in a Row

After Mizuho Securities and Stifel Nicolaus gave Zogenix (NASDAQ: ZGNX) a Buy rating last month, the company received another Buy, this time from Northland Securities. Analyst Carl Byrnes maintained a Buy rating on Zogenix today and set a price target